Table 3.
All Epithelial (n = 767) |
Serous Invasive (n = 397) |
Endometrioid (n = 118) |
Mucinousc (n = 80) |
P-Heterogeneityd | |||||
RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | ||
Ovulatory years (per 1-year increase)e | 1.07 | 1.05, 1.08 | 1.08 | 1.06, 1.10 | 1.08 | 1.05, 1.11 | 1.03 | 1.00, 1.07 | 0.04 |
Duration of menopause (per 1-year increase) | 1.02 | 1.01, 1.04 | 1.04 | 1.02, 1.06 | 0.96 | 0.93, 0.99 | 1.00 | 0.97, 1.04 | <0.001 |
Breastfeeding (per 1-year increase)f | 0.80 | 0.71, 0.89 | 0.85 | 0.73, 0.98 | 0.68 | 0.49, 0.94 | 0.45 | 0.27, 0.77 | 0.03 |
Tubal ligation | 0.69 | 0.55, 0.85 | 0.86 | 0.65, 1.16 | 0.57 | 0.32, 1.00 | 0.51 | 0.25, 1.04 | 0.21 |
Hysterectomy | 0.69 | 0.52, 0.92 | 0.77 | 0.53, 1.13 | 0.78 | 0.42, 1.44 | 0.57 | 0.23, 1.42 | 0.81 |
Estrogen use (per 5-year increase)g | 1.36 | 1.13, 1.64 | 1.45 | 1.16, 1.81 | 2.33 | 1.53, 3.53 | 0.93 | 0.38, 2.26 | 0.08 |
Abbreviations: CI, confidence interval; NHS, Nurses’ Health Study; NHSII, Nurses’ Health Study II; RR, incidence rate ratio.
Estimates were adjusted for all variables in the table, plus cohort (NHS or NHSII), parous (yes/no), menopausal status (postmenopause vs. premenopause/perimenopause), and missing data on breastfeeding duration (yes/no) because of noncompletion of questionnaire.
Model excludes women with missing age at natural menopause because of hysterectomy prior to menopause.
Includes borderline and invasive tumors.
P value from likelihood ratio test comparing, for each covariate, the model with separate estimates for the serous invasive, endometrioid, and mucinous histologic subtypes with the model with a single estimate across the 3 subtypes.
Current age (if premenopausal) or age at natural menopause minus (age at menarche + duration of oral contraceptive use in years + parity).
Breastfeeding duration first collected in 1986 in the NHS and 1993 in the NHSII.
Duration of postmenopausal use of unopposed estrogens.